sec filing
AMEX · PLX
Protalix BioTherapeutics, Inc. Common Stock
Healthcare · Biotechnology
$2.73
Down-$0.09 (-3.30%)
Updated Sep 11, 2026, 10:13 PM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 146.37M
- P/E ratio
- 26.75
- Dividend yield
- 0.00%
- 52-week range
- $1.88 – $2.98
- Volume
- 782.52K
- Avg. volume
- 789.76K
Price performance
PLX price history
1M range · 20 trading sessions · Daily adjusted prices
PLX closed at $2.73 after 20 trading sessions, up 15.68% for the selected period.
- Last close
- $2.73
- Period change
- +15.68%
- Period low
- $2.22
- Period high
- $2.73
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $2.66 | $2.735 | $2.64 | $2.73 | 782.52K |
| Sep 9, 2026 | $2.68 | $2.68 | $2.595 | $2.67 | 580K |
| Sep 8, 2026 | $2.66 | $2.67 | $2.60 | $2.65 | 908.36K |
| Sep 4, 2026 | $2.62 | $2.68 | $2.615 | $2.67 | 863.72K |
| Sep 3, 2026 | $2.59 | $2.665 | $2.57 | $2.62 | 942.01K |
| Sep 2, 2026 | $2.59 | $2.64 | $2.585 | $2.59 | 454.86K |
| Sep 1, 2026 | $2.61 | $2.67 | $2.565 | $2.59 | 598.26K |
| Aug 31, 2026 | $2.55 | $2.61 | $2.525 | $2.57 | 748.35K |
| Aug 28, 2026 | $2.61 | $2.62 | $2.53 | $2.54 | 490.23K |
| Aug 27, 2026 | $2.49 | $2.65 | $2.48 | $2.61 | 1.29M |
| Aug 26, 2026 | $2.39 | $2.48 | $2.36 | $2.48 | 1.02M |
| Aug 25, 2026 | $2.43 | $2.43 | $2.38 | $2.40 | 497.74K |
| Aug 24, 2026 | $2.36 | $2.43 | $2.34 | $2.41 | 409.93K |
| Aug 21, 2026 | $2.39 | $2.435 | $2.35 | $2.38 | 648.55K |
| Aug 20, 2026 | $2.32 | $2.39 | $2.3101 | $2.38 | 384.98K |
| Aug 19, 2026 | $2.37 | $2.38 | $2.31 | $2.35 | 477.24K |
| Aug 18, 2026 | $2.30 | $2.345 | $2.28 | $2.34 | 280.51K |
| Aug 17, 2026 | $2.24 | $2.365 | $2.22 | $2.29 | 1.08M |
| Aug 14, 2026 | $2.36 | $2.36 | $2.17 | $2.22 | 995.92K |
| Aug 13, 2026 | $2.64 | $2.64 | $2.32 | $2.36 | 2M |
Latest PLX news
The latest Smart Investors Daily articles mentioning PLX.
Stock researchMarket Activity · Institutional Ownership
Loading stock research…